John Frederick Ek - Apr 1, 2025 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
CFO
Signature
/s/ John Frederick Ek, by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Apr 1, 2025
Transactions value $
-$22,183
Form type
4
Date filed
4/3/2025, 05:14 PM
Previous filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Tax liability -$22.2K -16.4K -6.21% $1.35 248K Apr 1, 2025 Direct F1
holding AKYA Common Stock 20K Apr 1, 2025 Ek Trust Dated November 20, 2020
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to cover taxes on a restricted stock unit award previously granted on March 20, 2023, which vests in four (4) annual equal installments beginning on April 1, 2024 and annually thereafter until fully vested.